Associate Director, Global Oncology Marketing, Biomarker Strategy at Daiichi Sankyo US | New Jersey, USA | $162K/yr – $244K/yr

Daiichi Sankyo US

Associate Director, Global Oncology Marketing, Biomarker Strategy

New Jersey, USA (On-site)

$162K/yr – $244K/yrSenior Level7+ years expFull time

Posted 6 weeks ago

Top 1% of applicants do these two things.

The other 99% submit and hope. You're about to do something different.

Job Summary

Lead a global, data driven HER2 Diagnostics program across regions with alliance partners, translating regional needs into a unified, compliant strategy while keeping escalation and alignment tight.

Regional Collaboration: Align regional inputs, minimize redundancy, and push for high-impact diagnostic programs.
Diagnostics Insights: Build a KPI driven view of patient ID challenges and refine strategies across the product lifecycle.
Alliance Partnership: Steer compliance submissions and milestone driven approvals to unlock regional resources.

Job Description

Regional Collaboration: Partner with regional and local DS affiliates to optimize identification of ENHERTU eligible patients. Engage alliance partners to gather input on global diagnostics plans and activities, ensuring programs are aligned across regions with minimal redundancy and maximum impact. Serve as the primary global escalation and alignment lead for HER2 Diagnostics. Monitor local unmet needs and resourcing requirements and improve market clarity by leading best practice exchange forums and routine stakeholder updates.
Cross-functional Collaboration: Drive cross functional engagement and alignment on core initiatives, with emphasis on Pathology & Laboratory Enablement programs. Ensure commercial activities (including pathology education) complement medical initiatives and close strategic/tactical diagnostic gaps. Provide commercial brand teams with regular updates on diagnostic landscape trends, stakeholder insights, and key pathology related milestones. Contribute to business and financial planning with the brand indication teams. Serve as the commercial escalation and alignment point for HER2 Diagnostics, interfacing with medical counterparts.
Diagnostics Insights & Tracking: Build and maintain a robust understanding of patient identification challenges across the global diagnostics landscape for each HER2 biomarker program. Leverage primary market research, secondary data analyses, and voice-of-customer insights from key stakeholders. Apply expertise to challenge strategic and tactical assumptions and refine diagnostic strategies across the product lifecycle, considering competitive pressures, disease prevalence(s), test proficiency / quality assurance, and market access dynamics. Identify barriers and close gaps through practical, market appropriate frameworks. Define and recommend critical KPIs—and their evolution over time—to monitor diagnostic testing performance and support the overarching commercial strategies.
Alliance Partnership: Establish and sustain effective collaboration with DS’ alliance partner, ensuring alignment across cross functional project teams. Lead end to end submission of materials through required compliance processes. Secure approvals on schedule to meet critical milestones and enable delivery of resources to regional and local affiliates.

Daiichi Sankyo US

At Daiichi Sankyo, we create essential medicine for longer, better lives. By uniting cutting edge science and technology with a genuine interest in people, we develop high quality, life changing solutions for the patients of today and tomorrow with great care and unwavering dedication.With more than 125+ years of experience, Daiichi Sankyo leverages its world-class science and technology to create new modalities and innovative medicines for people with cancer, cardiovascular, and other diseases with high unmet medical need. For more information, please visit www.daiichisankyo.us.See our community guidelines here: https://bit.ly/4fLkZS8

Founded in 2005

Basking Ridge, New Jersey, USA

4.3K employees (237 in marketing)

daiichisankyo.us